Adipose-Derived Stromal Cells in Regenerative Medicine: A Review

In the 2017 review, adipose-derived stromal cells (ADSCs) were presented as a promising cell source for regenerative medicine due to their ease of isolation, high cell yield, and low sampling risk compared to other stem cells like those from bone marrow. ADSCs have been used in treating a variety of diseases, including hair loss, and have shown immune modulation, anti-ulcer, and anti-inflammatory properties. They are generally considered safe, with clinical trials reporting no severe adverse effects, although there is concern about their potential to promote cancer growth in cosmetic reconstructive surgery. The review calls for further research to fully assess the safety and efficacy of ADSCs in disease treatment, despite their demonstrated therapeutic potential.